<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115836">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01595217</url>
  </required_header>
  <id_info>
    <org_study_id>XYang</org_study_id>
    <nct_id>NCT01595217</nct_id>
  </id_info>
  <brief_title>The Diagnosis of Biliary Tract Neoplasm by Diffusion Weighted Imaging and Magnetic Resonance Cholangiopancreatography</brief_title>
  <official_title>The Application of Combining Diffusion Weighted Imaging(DWI) and Magnetic Resonance Cholangiopancreatography(MRCP) at 3.0T MRI in the Diagnosis of Biliary Tract Neoplasm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researching the diagnostic significance of Biliary Tract Neoplasm under combining DWI
      sequence with MRCP versus MRCP only separately.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to evaluate the usefulness of diffusion weighted imaging(DWI)
      combined with MRCP of 3-T magnetic resonance imaging (MRI) in the evaluation of suspected
      malignant bile duct diseases.People with suspected Biliary Tract Neoplasm based on clinical
      symptoms(such as jaundice and thinness with unknown reasons)and CA-199 value raises are
      included.Diagnosis divided into two steps: the first one，only provide conventional MR
      sequences and MRCP images to make a diagnosis; the second step,provide the DWI images
      additionally, combining the image data before to make a diagnosis.Hypothesis is that DWI
      sequence should be regularly added into MRCP examination for improving diagnosis rate of
      Biliary Tract Neoplasm.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Biliary Tract Neoplasm diagnoses in MRCP with DWI and MRCP only groups</measure>
    <time_frame>at the end of the study (up to 1 year)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of positive biopsies in MRCP with DWI and MRCP only groups</measure>
    <time_frame>at the end of the study (up to 1 year)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Biliary Tract Neoplasm</condition>
  <arm_group>
    <arm_group_label>MRCP and DWI using 3T MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRCP and DWI using Magnetic resonance imaging（GE Signa,3.0 T )</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRCP only using 3T MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRCP only using Magnetic resonance imaging（GE Signa,3.0 T )</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3T MRI</intervention_name>
    <description>diffusion weighted imaging(DWI) of biliary tract with GE Signa 3-tesla device</description>
    <arm_group_label>MRCP and DWI using 3T MRI</arm_group_label>
    <arm_group_label>MRCP only using 3T MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Suspected Biliary Tract Neoplasm based on clinical symptoms(such as jaundice and
             thinness with unknown reasons)and CA-199 raises（＞37U/mL）

          -  No evidence of clinical symptoms or CA-199 increase by non-bile duct cancerous
             factors(hepatitis,cholangeitis,stones)

          -  Age ≥ 16

        Exclusion Criteria:

          -  Previous Biliary Tract Neoplasm surgery

          -  Contraindication for MRI (such as pacemaker or inner ear implant)

          -  Claustrophobia

          -  Age &lt; 16
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ke Ren, Professor</last_name>
    <role>Study Director</role>
    <affiliation>First affiliated Hospital of China medical university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Room of 3.0TMR in the FAH of CMU</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ke Ren, Professor</last_name>
      <phone>13940283566</phone>
      <phone_ext>024-83282305</phone_ext>
      <email>renke815@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 9, 2012</lastchanged_date>
  <firstreceived_date>May 8, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Xiaoping Yang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Biliary Tract Neoplasm</keyword>
  <keyword>MRI</keyword>
  <keyword>DWI</keyword>
  <keyword>Diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
